Cutaneous Sarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-01
Clinical Trial Update: Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma [Phase 2]
A Phase 2 trial is investigating pembrolizumab for advanced cutaneous sarcomas not including angiosarcoma; the study is currently recruiting…